advanced search

Advanced Skills

Home Medical Service Advanced Skills Content

Original technology of Professor Lu Shaoying of the Department of Vascular Surgery presented in the world stage

Updated: Nov 23, 2018
From: Department of Vascular Surgery
Edited by:

On the morning of November 15 in New York time, Professor Lu Shaoying, PhD Supervisor of vascular surgery in the First Affiliated Hospital of Xi’an Jiaotong University (hereinafter referred to as “Hospital”), was invited to attend the 45th "VEITH SYMPOSIUM" held in New York. VEITH SYMPOSIUM is the largest academic conference onvascular surgery and interventional vascular professionin the world. In this meeting, Professor Lu presented a special report on the original technology of the Hospital with the title of “Minimally Invasive Treatment of Iatrogenic Pseudoaneurysms of Lower Extremity Vascular Approach”.

The “VEITH SYMPOSIUM”, known as “Vascular Endovascular Issue Techniques Horizons”, is the global academic conference on vascular surgery advocated and initiated by Professor Frank J. Veith, former President of Society of Vascular Surgery, USA (the first person who performed the open abdominal aortic aneurysm resection). It is also the largest, oldest and most authoritative academic feast of vascular surgery in the world, and has been successfully held for 45 sessions. At this conference, Professor Lu of the Hospital made an academic speech at the Youth Conference Hall of VEITH SYMPOSIUM for two consecutive years.

Professor Lu applied minimally invasive techniques in the treatment of iatrogenic pseudoaneurysms in clinical practice. Based on literature search results, we found that this technique is pioneered by the Hospital in Asia. Only the German doctors reported similar surgeries in 2017 worldwide (only seven cases completed). The technique applies the existing vascular suture device and single-visit minimally invasive suture of the lower extremity iatrogenic pseudoaneurysm of the neck, which can effectively treat the disease in a minimal invasive manner. Therefore, it significantly increases the cure rate of the disease, minimizes operation risk, as well as accelerates the operation speed and improves the living quality of the patients. The abstract of the paper is published in the supplement of Journal of Vascular Surgery, the most well-known journal of vascular surgery.

Previous:Our hospital independently completes TAVR for the first time
Next:"Clinical Research Project of New CART Cell Therapy for Hematologic Neoplasms” was launched in our hospital

Copyright (c) 2011, First Affiliated Hospital of Xi 'an Jiaotong University Shaanxi ICP for 12009712-3